Detalhe da pesquisa
1.
Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study.
Int J Cancer
; 154(1): 28-40, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615573
2.
State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.
Int J Cancer
; 154(4): 596-606, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715370
3.
Implementation considerations for risk-tailored cancer screening in the population: A scoping review.
Prev Med
; 181: 107897, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378124
4.
Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
JAMA
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583868
5.
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
Int J Cancer
; 152(9): 2002-2010, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305647
6.
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
Cancer
; 129(15): 2373-2384, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37032449
7.
Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage.
Br J Cancer
; 129(8): 1209-1211, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726480
8.
The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
Int J Cancer
; 151(9): 1491-1501, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809038
9.
Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Br J Cancer
; 124(12): 2026-2034, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846525
10.
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme.
Thorax
; 75(8): 661-668, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631933
11.
PATHFINDER: another step on the uncharted path to multicancer screening.
Lancet
; 402(10409): 1213-1215, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805199
12.
Opioid medications: an emerging cancer risk factor?
Br J Anaesth
; 130(3): e401-e403, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682937
14.
Short Stature and Access to Lung Transplantation in the United States. A Cohort Study.
Am J Respir Crit Care Med
; 193(6): 681-8, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554631
15.
Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Br J Cancer
; 125(2): 305, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002041
16.
Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansion.
Biostatistics
; 16(1): 169-78, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24907707
17.
Biomarkers in lung cancer screening: the importance of study design.
Eur Respir J
; 57(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446580
18.
Multilevel correlates of broadly- and narrowly-defined intimate partner violence among pregnant women in Los Angeles.
Matern Child Health J
; 19(7): 1643-51, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636648
19.
Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States.
Ann Intern Med
; 171(5): 384-386, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158854
20.
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
BMC Infect Dis
; 14: 120, 2014 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24588945